The European Molecular Biology Organization (EMBO) awards the prize annually to a practicing scientist in Europe for outstanding communication with the public.
Juergen Tautz is a world-leading zoologist with a particular interest in exploring the life and evolution of honeybees.
He considers them an optimal model system to investigate the inner structure and functioning of highly complex systems exhibiting "intelligent" behaviour. Honeybees are currently under threat of extinction and illustrate the dangers of global warming to animals and humans.
As a science communicator, Tautz targets teachers, high-school and university students as well as broader public audiences - with considerable success. His 2007 published book Phaenomen Honigbiene (The Buzz about Bees - Biology of a Superorganism) has been published in almost all European languages, last year also Arabic, Chinese and Korean versions joined the list. His three-minute trailer about the life of honeybees preceding the Dreamworks blockbuster Bee Movie was shown at about 10,000 screenings in more than 80 theatres throughout Germany. "The honeybee is the perfect lever especially to reach the youth," commented Juergen Tautz.
In addition to his book, the award winner gives frequent interviews and is the founder and head of an association promoting research on honeybees and raising funds for communication activities (more information at www.beegroup.de). The numerous lectures he gives to lay audiences in museums, schools and universities form another important part of his persistent communication and educational work.
Tautz also pursues an active research programme in his capacity as professor and head of the BEEgroup at the Biocenter of the University of Wuerzburg. He has published 140 scientific articles and given more than 400 lectures at universities worldwide. His research focus is honeybee biology and specifically the principles of disease resistance.
Juergen Tautz will receive the discretionary prize of 2,500 euro at the 7th Annual ELSO Meeting in Nice, France, on 1 September 2008.
Suzanne Beveridge | idw
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
Improving the understanding of death receptor functions in cells
07.11.2018 | Goethe-Universität Frankfurt am Main
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
10.12.2018 | Event News
06.12.2018 | Event News
03.12.2018 | Event News
12.12.2018 | Trade Fair News
12.12.2018 | Information Technology
12.12.2018 | Life Sciences